NEW YORK, June 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

U.S. Asthma/COPD Market

http://www.reportlinker.com/p0490645/US-Asthma/COPD-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

This research service provides an in depth analysis of factors affecting the growth of the U.S. asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by mechanisms of action: anti-inflammatories, bronchodilators, and combination therapies. Major market challenges, drivers, and restraints and identified and discussed. Included are examinations of therapeutic candidates in the asthma/COPD pipeline for phase III.

Table of Contents

C h a p t e r 1

Executive Summary

U.S. Asthma/COPD Market 1-1

Introduction 1-1

C h a p t e r 2

Market Introduction

Research Scope and Methodology 2-1

Scope and Segmentation 2-1

Research Methodology 2-2

Assumptions in Revenue Forecasts: 2-3

Market Overview 2-4

Asthma Disease Overview 2-4

Disease Definition 2-4

Risk Factors 2-4

Disease Classification 2-6

COPD Disease Overview 2-6

Disease Definition 2-6

Risk Factors 2-7

Disease Classification 2-8

Market Engineering Measurements 2-8

Market Age 2-9

Base Year Revenues 2-10

Potential Revenues for 2016 2-10

Base Year Market Growth Rate 2-10

Compound Annual Growth Rate 2-10

Active Market Competitors in Base Year 2-10

Base Year Market Concentration 2-10

Number of New Products in Phase III Trials 2-11

Price Sensitivity 2-11

Patient Forecasts—Asthma 2-11

Patient Forecasts—COPD 2-13

Total Patient Forecasts 2-16

Industry Challenges 2-18

Low Patient Awareness Inhibits Market Size 2-18

Need for Market Specific Expertise Inhibits Entry of New Participants 2-19

Lack of Patient Compliance Hinders Market Growth 2-19

Absence of Effective Treatments Slows Market Growth 2-20

Market Drivers 2-20

Increasing Incidence of Asthma and COPD Drives Market Growth 2-20

Lack of Generic Inhalers on the Market Inflates Prices and Revenue 2-21

Introduction of New Drug Classes Promotes Market Expansion 2-21

Market Restraints 2-21

Adverse Side Effects Deter Patients from Using Medication 2-22

Expected Entry of Generic Products Impedes Revenue Growth 2-23

Bronchodilators Product Analysis 2-23

Short-Acting Bronchodilators Product Analysis 2-23

Xopenex HFA (levalbuterol) 2-24

Long-Acting Bronchodilators Product Analysis 2-25

Foradil Aerolizer (formoterol fumarate) 2-25

Anticholinergics Product Analysis 2-26

Spiriva Handihaler (tiotropium bromide monohydrate) 2-27

Combination Bronchodilators Product Analysis 2-28

Combivent Inhalation Aerosol (albuterol sulfate/iprotropium bromide) 2-28

Anti-Inflammatories Product Analysis 2-29

Inhaled Corticosteroids Product Analysis 2-29

Pulmicort Respules (budesonide) 2-30

Anti-Leukotriene Product Analysis 2-30

Singulair (montelukast sodium) 2-31

Monoclonal Antibodies Product Analysis 2-31

Xolair (omalizumab) 2-32

Combination Therapies Product Analysis 2-33

Combination Therapies Product Analysis 2-33

Advair (fluticasone/salmeterol) 2-33

Pipeline Analysis 2-34

Phase III Pipeline Analysis 2-34

QAB 149 (Indacaterol) 2-35

NVA 237 2-35

QVA 149 2-36

Daxas (roflumilast) 2-36

C h a p t e r 3

Competitive Analysis

Total Market Forecasts 3-1

Revenue Forecasts for Total Asthma/COPD Market 3-1

Revenue Forecasts for Bronchodilators 3-4

Revenue Forecasts for All Bronchodilators 3-4

Revenue Forecasts for Short-Acting Bronchodilators 3-6

Revenue Forecasts for Long-Acting Bronchodilators 3-9

Revenue Forecasts Anticholinergics 3-13

Revenue Forecasts for Combination Bronchodilators 3-16

Revenue Forecasts for Anti-Inflammatories 3-19

Revenue Forecasts for All Anti-Inflammatories 3-19

Revenue Forecasts for Inhaled Corticosteroids 3-21

Revenue Forecasts for Anti-Leukotrienes 3-25

Revenue Forecasts for Monoclonal Antibodies 3-28

Revenue Forecasts for Other Emerging Anti-Inflammatories 3-29

Revenue Forecasts for Combination Therapies 3-31

Revenue Forecasts for Combination Therapies 3-31

Competitive Analysis 3-35

Competitive Structure 3-35

Number and Types of Competitors 3-36

Key End-user Groups 3-36

Competitive Factors 3-36

Market Share Analysis 3-36

Company Market Share 3-36

Product Market Share 3-39

C h a p t e r 4

Appendix

Decision Support Databases 4-1

Mortality Due to Asthma-Bronchitis-and-Emphysema 4-1

Prevalence of Asthma 4-3

Prevalence of COPD 4-5

Mortality Due to Respiratory Disease 4-7

Total Population Over 65 4-10

List of Figures

C h a p t e r 2

Market Introduction

2-1 Asthma/COPD Market:

Asthma Patient Forecasts by Age Bracket (U.S.), 2006-2016 2-12

2-2 Asthma/COPD Market:

COPD Patient Forecasts by Age Bracket (U.S.), 2006-2016 2-14

2-3 Asthma/COPD Market:

Emphysema and Chronic Bronchitis Patient Forecasts (U.S.), 2006-2016 2-15

2-4 Asthma/COPD Market:

Asthma and COPD Patient Forecasts (U.S.), 2006-2016 2-17

2-5 Asthma/COPD Market:

Top Four Industry Challenges (U.S.), 2010-2016 2-18

2-6 Asthma/COPD Market:

Market Drivers Ranked in Order of Impact (U.S.), 2010-2016 2-20

2-7 Asthma/COPD Market:

Major Market Restraints Ranked in Order of Impact (U.S.), 2010-2016 2-22

2-8 Asthma/COPD Market:

Product Analysis for Selected Short-Acting Bronchodilators (U.S.), 2009 2-24

2-9 Asthma/COPD Market:

Product Analysis for Selected Long-Acting Bronchodilators (U.S.), 2009 2-25

2-10 Asthma/COPD Market:

Product Analysis for Selected Anticholinergics (U.S.), 2009 2-27

2-11 Asthma/COPD Market:

Product Analysis for Selected Combination Bronchodilators (U.S.), 2009 2-28

2-12 Asthma/COPD Market:

Product Analysis for Selected Inhaled Corticosteroids (U.S.), 2009 2-29

2-13 Asthma/COPD Market:

Product Analysis for Selected Anti-Leukotriene (U.S.), 2009 2-30

2-14 Asthma/COPD Market:

Product Analysis for Monoclonal Antibodies (U.S.), 2009 2-31

2-15 Asthma/COPD Market:

Product Analysis for Combination Therapies (U.S.), 2009 2-33

2-16 Asthma/COPD Market:

Phase III Pipeline Analysis (U.S.), 2010 2-35

C h a p t e r 3

Competitive Analysis

3-1 Asthma/COPD Market:

Revenue Forecasts (U.S.), 2006-2016 3-1

3-2 Asthma/COPD Market:

Revenue Forecasts by Market Segment (U.S.), 2006-2016 3-3

3-3 Asthma/COPD Market:

Revenue Forecasts for Bronchodilators (U.S.), 2006-2016 3-4

3-4 Asthma/COPD Market:

Revenue Forecasts for Short-Acting Bronchodilators (U.S.), 2006-2016 3-6

3-5 Asthma/COPD Market:

Revenue Forecasts by Product for Short-Acting Bronchodilators (U.S.), 2006-2016 3-7

3-6 Asthma/COPD Market:

Revenue Forecasts for Long-Acting Bronchodilators (U.S.), 2006-2016 3-10

3-7 Asthma/COPD Market:

Revenue Forecasts by Product for Long-Acting Bronchodilators (U.S.), 2006-2016 3-11

3-8 Asthma/COPD Market:

Revenue Forecasts for Anticholinergics (U.S.), 2006-2016 3-13

3-9 Asthma/COPD Market:

Revenue Forecasts by Product for Anticholinergics (U.S.), 2006-2016 3-15

3-10 Asthma/COPD Market:

Revenue Forecasts for Combination Bronchodilators (U.S.), 2006-2016 3-16

3-11 Asthma/COPD Market:

Revenue Forecasts by Product for Combination Bronchodilators (U.S.), 2006-2016 3-18

3-12 Asthma/COPD Market:

Revenue Forecasts for Anti-Inflammatories (U.S.), 2006-2016 3-20

3-13 Asthma/COPD Market:

Revenue Forecasts for Inhaled Corticosteroids (U.S.), 2006-2016 3-21

3-14 Asthma/COPD Market:

Revenue Forecasts by Product for Inhaled Corticosteroids (U.S.), 2006-2016 3-23

3-15 Asthma/COPD Market:

Revenue Forecasts for Anti-Leukotrienes (U.S.), 2006-2016 3-25

3-16 Asthma/COPD Market:

Revenue Forecasts by Product for Anti-Leukotrienes (U.S.), 2006-2016 3-27

3-17 Asthma/COPD Market:

Revenue Forecasts for Monoclonal Antibodies (U.S.), 2006-2016 3-28

3-18 Asthma/COPD Market:

Revenue Forecasts for Other Emerging Anti-Inflammatories (U.S.), 2006-2016 3-30

3-19 Asthma/COPD Market:

Revenue Forecasts for Combination Therapies (U.S.), 2006-2016 3-32

3-20 Asthma/COPD Market:

Revenue Forecasts by Product for Combination Therapies (U.S.), 2006-2016 3-33

3-21 Asthma/COPD Market:

Competitive Structure (U.S.), 2009 3-35

3-22 Asthma/COPD Market:

Company Market Share by Revenues (U.S.), 2009 3-37

3-23 Asthma/COPD Market:

Company Market Share by Revenues (U.S.), 2016 3-38

3-24 Asthma/COPD Market:

Product Market Share by Revenues (U.S.), 2009 3-39

3-25 Asthma/COPD Market:

Product Market Share by Revenues (U.S.), 2016 3-40

C h a p t e r 4

Appendix

4-1 Decision Support Database:

Mortality due to Asthma, Bronchitis and Emphysema (World), 2002-2012 4-1

4-2 Decision Support Database:

Prevalence of Asthma in Million (World), 2002-2012 4-3

4-3 Decision Support Database:

Population with COPD in '000 (World), 2002-2012 4-5

4-4 Decision Support Database:

Mortality due to Respiratory Disease in '000 (World), 2002-2012 4-8

4-5 Decision Support Database:

Population 65 Plus in Million (World), 2004-2014 4-10

List of Charts

C h a p t e r 2

Market Introduction

2.1 Asthma/COPD Market:

Market Segmentation (U.S.), 2010 2-2

2.2 Asthma/COPD Market:

Market Engineering Measurements (U.S.), 2009 2-9

2.3 Asthma/COPD Market:

Asthma Patient Forecasts by Age Bracket (U.S.), 2006-2016 2-12

2.4 Asthma/COPD Market:

COPD Patient Forecasts by Age Bracket (U.S.), 2006-2016 2-14

2.5 Asthma/COPD Market:

Emphysema and Chronic Bronchitis Patient Forecasts (U.S.), 2006-2016 2-16

2.6 Asthma/COPD Market:

Asthma and COPD Patient Forecasts (U.S.), 2006-2016 2-17

C h a p t e r 3

Competitive Analysis

3.1 Asthma/COPD Market:

Revenue Forecasts (U.S.), 2006-2016 3-2

3.2 Asthma/COPD Market:

Market Revenue Forecasts by Segment (U.S.), 2006-2016 3-3

3.3 Asthma/COPD Market:

Revenue Forecasts for Bronchodilators (U.S.), 2006-2016 3-5

3.4 Asthma/COPD Market:

Revenue Forecasts for Short-Acting Bronchodilators (U.S.), 2006-2016 3-7

3.5 Asthma/COPD Market:

Revenue Forecasts by Product for Short-Acting Bronchodilators (U.S.), 2006-2016 3-8

3.6 Asthma/COPD Market:

Revenue Forecasts for Long-Acting Bronchodilators (U.S.), 2006-2016 3-10

3.7 Asthma/COPD Market:

Revenue Forecasts by Product for Long-Acting Bronchodilators (U.S.), 2006-2016 3-12

3.8 Asthma/COPD Market:

Revenue Forecasts for Anticholinergics (U.S.), 2006-2016 3-14

3.9 Asthma/COPD Market:

Revenue Forecasts by Product for Anticholinergics (U.S.), 2006-2016 3-15

3.10 Asthma/COPD Market:

Revenue Forecasts for Combination Bronchodilators (U.S.), 2006-2016 3-17

3.11 Asthma/COPD Market:

Revenue Forecasts by Product for Combination Bronchodilators (U.S.), 2006-2016 3-18

3.12 Asthma/COPD Market:

Revenue Forecasts for Anti-Inflammatories (U.S.), 2006-2016 3-20

3.13 Asthma/COPD Market:

Revenue Forecasts for Inhaled Corticosteroids (U.S.), 2006-2016 3-22

3.14 Asthma/COPD Market:

Revenue Forecasts by Product for Inhaled Corticosteroids (U.S.), 2006-2016 3-23

3.15 Asthma/COPD Market:

Revenue Forecasts for Anti-Leukotrienes (U.S.), 2006-2016 3-26

3.16 Asthma/COPD Market:

Revenue Forecasts by Products for Anti-Leukotrienes (U.S.), 2006-2016 3-27

3.17 Asthma/COPD Market:

Revenue Forecasts for Monoclonal Antibodies (U.S.), 2006-2016 3-29

3.18 Asthma/COPD Market:

Revenue Forecasts for Other Emerging Anti-Inflammatories (U.S.), 2006-2016 3-30

3.19 Asthma/COPD Market:

Revenue Forecasts for Combination Therapies (U.S.), 2006-2016 3-32

3.20 Asthma/COPD Market:

Revenue Forecasts by Products for Combination Therapies (U.S.), 2006-2016 3-34

3.21 Asthma/COPD Market:

Company Market Share by Revenues (U.S.), 2009 3-37

3.22 Asthma/COPD Market:

Company Market Share by Revenues (U.S.), 2016 3-39

3.23 Asthma/COPD Market:

Product Market Share by Revenues (U.S.), 2009 3-40

3.24 Asthma/COPD Market:

Product Market Share by Revenues (U.S.), 2016 3-41

To order this report:

Drug and Medication Industry: U.S. Asthma/COPD Market

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com